Insulin-like growth factor binding protein (IGFBP7) and tissue inhibitor of metalloproteinases-2 (TIMP-2) were evaluated in Zhang et al. [147] study, which has shown that these two biomarkers are not able to distinguish between HRS and preserved kidney function in patients with cirrhosis. The gene discussed is TIMP2; the disease is Cirrhosis.